Superior vena cava syndrome caused by embolisation of liquid Onyx.

BMJ Case Rep

Department of Medicine, Division of Pulmonary & Critical Care Medicine, Maimonides Medical Center, Brooklyn, New York, USA.

Published: February 2011

Superior vena cava syndrome (SVCS) is usually caused by a malignancy or the presence of an intravascular device in a central vein. A 74-year-old male with a history of a superior vena cava (SVC) stent underwent embolisation of a brain arterio-venous malformation through the right meningeal artery with liquid Onyx. Two weeks later he presented with acute respiratory failure, upper airway obstruction, plethora, varices of the chest wall and stridor. He was intubated and placed on mechanical ventilatory support. Chest imaging revealed a linear structure in the SVC, extending to the right atrium. Interventional radiology removed the material, which was determined to be liquid Onyx. Venous pressures of the right internal jugular vein decreased after removal of the material. The symptoms resolved and patient was successfully extubated. This is the first reported case of SVCS caused by liquid Onyx.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062888PMC
http://dx.doi.org/10.1136/bcr.11.2010.3502DOI Listing

Publication Analysis

Top Keywords

liquid onyx
16
superior vena
12
vena cava
12
cava syndrome
8
svcs caused
8
syndrome caused
4
caused embolisation
4
liquid
4
embolisation liquid
4
onyx
4

Similar Publications

Hemodynamic Instability during Squid Embolization of Dural Arteriovenous Fistula: A Case Report.

Neurointervention

December 2024

Department of Neuroradiology, Neuroscience Institute, Hamad Medical Corporation, Hamad General Hospital, Doha, Qatar.

Article Synopsis
  • A case is presented involving a patient with a ruptured paramedian occipital DAVF who experienced sudden sinus bradycardia during embolization while inflating balloons in the occipital arteries.
  • The medical team managed the situation by temporarily stopping the injections and deflating the balloons, allowing for a successful third injection that completely excluded the fistula without further complications.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on evaluating the long-term outcomes and natural history of chronic subdural hematoma (cSDH) treatment using middle meningeal artery (MMA) embolization over a 12-month period.
  • A retrospective analysis was conducted involving 49 patients who underwent MMA embolization, detailing patient demographics and various clinical outcomes, including symptom resolution and recurrence rates.
  • Results indicated significant clinical improvement in patients within one month post-procedure, with many elderly patients (average age 73) experiencing previous trauma mainly due to falls.
View Article and Find Full Text PDF

Background: Dural arteriovenous fistula (DAVF) in the anterior cranial fossa (ACF) is known to show a high risk of intracranial hemorrhage. Recently, multi-modal fusion imaging with computed tomography angiography, computed tomography venography, and three-dimensional (3D) rotation angiography have been used preoperatively to ensure anatomical safety. We report on endovascular treatment as a first-line approach for ACFDAVF based on the understanding of vascular anatomy obtained from multi-modal fusion imaging.

View Article and Find Full Text PDF

Background: The benefit of distal embolite penetration for middle meningeal artery (MMA) embolization in chronic subdural hematomas (cSDH) remains controversial.

Objective: To compare the use of diluted Onyx with undiluted Onyx in the management of cSDH.

Methods: This is a retrospective study of patients with cSDH who underwent MMA embolization using Onyx 18 at our institution.

View Article and Find Full Text PDF

Background And Objectives: Multiple preferences exist for embolic materials selection in middle meningeal artery embolization (MMAE) for chronic subdural hematoma with limited comparative literature data. Herein, we compare different embolic materials.

Methods: Consecutive patients undergoing MMAE for chronic subdural hematoma at 14 North-American centers (2018-2023) were classified into 3 groups: (a) particles, (b) Onyx, (c) n-butyl cyanoacrylate (n-BCA).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!